# A Study of KRN23 in Subjects With Tumor-Induced Osteomalacia or Epidermal Nevus Syndrome

> **NCT02722798** · PHASE2 · COMPLETED · sponsor: **Kyowa Kirin Co., Ltd.** · enrollment: 14 (actual)

## Conditions studied

- Tumor-Induced Osteomalacia or Epidermal Nevus Syndrome

## Interventions

- **DRUG:** KRN23

## Key facts

- **NCT ID:** NCT02722798
- **Lead sponsor:** Kyowa Kirin Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-04
- **Primary completion:** 2017-07
- **Final completion:** 2020-10
- **Target enrollment:** 14 (ACTUAL)
- **Last updated:** 2022-09-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02722798

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02722798, "A Study of KRN23 in Subjects With Tumor-Induced Osteomalacia or Epidermal Nevus Syndrome". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02722798. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*